{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:30:54Z","timestamp":1786336254256,"version":"build-2736575974"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background and purpose<\/jats:title>\n                    <jats:p>Inflammatory factors are pivotal in systemic and central nervous system inflammation post-stroke. This study examined if peripheral inflammatory factors were associated with outcomes after endovascular therapy for acute large vessel occlusion stroke by mediating infarct growth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective analysis of the EVTRNA (Circulating Non-coding RNA in Acute Ischemic Stroke with Endovascular Treatment) trial. Patients who underwent pre-endovascular therapy multimodal MRI, postoperative day 1 inflammatory factor testing, and postoperative day 7 head CT for infarct volume evaluation were included in this study. Unfavorable outcome was defined as a modified Rankin Scale score of 3\u20135 at the 90-day follow-up. Regression analysis and mediation analysis were employed to assess the association between inflammatory factors and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 105 patients were included in this study, of whom 51 experienced unfavorable outcomes. Univariate analysis demonstrated that elevated interleukin-6 (IL-6) levels, higher baseline National Institutes of Health Stroke Scale scores at admission, increased fasting blood glucose levels, and infarct growth were all significantly associated with unfavorable outcomes. After adjustment by multivariate analysis, IL-6 (odds ratio 1.02, 95% confidence interval 1.01-1.03) and the other aforementioned factors remained independently associated with unfavorable outcomes. Further mediation analysis revealed that infarct volume growth partially accounts for the unfavorable prognosis observed in patients with elevated IL-6 levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>IL-6 was associated with unfavorable outcomes in patients undergoing endovascular therapy. Postoperative infarct volume growth partially mediated the effect of IL-6 on clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1800891","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:21:43Z","timestamp":1786335703000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum IL-6 and functional outcome after endovascular therapy: the mediating role of infarct volume growth in acute ischemic stroke"],"prefix":"10.3389","volume":"17","author":[{"given":"Shuo","family":"Li","sequence":"first","affiliation":[{"name":"Department of Neurology, Nanjing First Hospital, Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated ZhongDa Hospital, School of Medicine, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifan","family":"Ji","sequence":"additional","affiliation":[{"name":"School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Qu","sequence":"additional","affiliation":[{"name":"School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing First Hospital, Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing First Hospital, Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing First Hospital, Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing First Hospital, Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Sun","sequence":"additional","affiliation":[{"name":"General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing First Hospital, Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing First Hospital, Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadong","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Lianshui County People\u2019s Hospital","place":["Huai\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwen","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing First Hospital, Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1161\/str.0000000000000481","article-title":"Large-core ischemic stroke endovascular treatment: A science advisory from the American Heart Association","volume":"56","author":"Gonzalez","year":"2025","journal-title":"Stroke"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1161\/str.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)00163-x","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet (London England)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0221-1","article-title":"Thrombo-inflammation in acute ischaemic stroke - implications for treatment","volume":"15","author":"Stoll","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2024.06.002","article-title":"The impact of cytokines in neuroinflammation-mediated stroke","volume":"78","author":"Kumari","year":"2024","journal-title":"Cytokine Growth Factor Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/0271678x221106956","article-title":"Cohort study on the differential expression of inflammatory and angiogenic factors in thrombi, cerebral and peripheral plasma following acute large vessel occlusion stroke","volume":"42","author":"Scott","year":"2022","journal-title":"J Cereb Blood Flow Metabolism: Off J Int Soc Cereb Blood Flow Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000011268","article-title":"Association of interleukin-6 levels and futile reperfusion after mechanical thrombectomy","volume":"96","author":"Mechtouff","year":"2021","journal-title":"Neurology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2147\/jir.s317147","article-title":"Inflammatory factors as potential markers of early neurological deterioration in acute ischemic stroke patients receiving endovascular therapy - The AISRNA study","volume":"14","author":"Deng","year":"2021","journal-title":"J Inflammation Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.123.044353","article-title":"What is a meaningful difference when using infarct volume as the primary outcome?: Results from the HERMES database","volume":"55","author":"Rinkel","year":"2024","journal-title":"Stroke"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.0572","article-title":"Endovascular thrombectomy for large ischemic stroke across ischemic injury and penumbra profiles","volume":"331","author":"Sarraj","year":"2024","journal-title":"Jama"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.32376","article-title":"Assessment of discrepancies between follow-up infarct volume and 90-day outcomes among patients with ischemic stroke who received endovascular therapy","volume":"4","author":"Ganesh","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-024-00689-4","article-title":"Infarct growth in patients with emergent large vessel occlusion stroke transferred for endovascular thrombectomy","volume":"14","author":"Xu","year":"2025","journal-title":"Neurol Ther"},{"key":"B13","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/biom15040470","article-title":"The role of IL-6 in ischemic stroke","volume":"15","author":"Pawluk","year":"2025","journal-title":"Biomolecules"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1159\/000536436","article-title":"Predictive clinical factors of in-hospital mortality in women aged 85 years or more with acute ischemic stroke","volume":"54","author":"Torres-Riera","year":"2025","journal-title":"Cerebrovascular Dis (Basel Switzerland)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1637732","article-title":"ADAMTS-13 activity predicts outcome in acute ischaemic stroke patients undergoing endovascular treatment","volume":"118","author":"Schuppner","year":"2018","journal-title":"Thromb Haemostasis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2015.06.004","article-title":"Interleukin-6 mediates enhanced thrombus development in cerebral arterioles following a brief period of focal brain ischemia","volume":"271","author":"Tang","year":"2015","journal-title":"Exp Neurol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.31.7.1715","article-title":"Lack of interleukin-6 expression is not protective against focal central nervous system ischemia","volume":"31","author":"Clark","year":"2000","journal-title":"Stroke"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000007859","article-title":"Neutrophil count predicts poor outcome despite recanalization after endovascular therapy","volume":"93","author":"Boisseau","year":"2019","journal-title":"Neurology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-4-2","article-title":"Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome","volume":"4","author":"Smith","year":"2004","journal-title":"BMC Neurol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.87.12.1141","article-title":"A role for platelets and endothelial selectins in tumor necrosis factor-alpha-induced leukocyte recruitment in the brain microvasculature","volume":"87","author":"Carvalho-Tavares","year":"2000","journal-title":"Circ Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000079815.38626.44","article-title":"Multiple levels of regulation of the interleukin-6 system in stroke","volume":"34","author":"Acalovschi","year":"2003","journal-title":"Stroke"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-023-02468-x","article-title":"Outcome of patients older than 85 years hospitalized in a neurology unit","volume":"35","author":"Querzola","year":"2023","journal-title":"Aging Clin Exp Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1689225","article-title":"Acute stroke in persons 85 years or older-clinical characteristics, impact of frailty, and predictors of outcome","volume":"16","author":"Sanner","year":"2025","journal-title":"Front Neurol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2026.1776458","article-title":"Immunosenescence and its impact on ischemic stroke risk and outcomes in older adults: A systematic review","volume":"18","author":"Seah","year":"2026","journal-title":"Front Aging Neurosci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/svn-2017-000123","article-title":"Stroke-induced immunosuppression and poststroke infection","volume":"3","author":"Shi","year":"2018","journal-title":"Stroke Vasc Neurol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.02.015","article-title":"Brain ischemia suppresses immunity in the periphery and brain via different neurogenic innervations","volume":"46","author":"Liu","year":"2017","journal-title":"Immunity"},{"key":"B27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12974-018-1142-4","article-title":"\u03b2-arrestin2 functions as a key regulator in the sympathetic-triggered immunodepression after stroke","volume":"15","author":"Wang","year":"2018","journal-title":"J Neuroinflamm"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14282","article-title":"MicroRNA-4443 regulates monocyte activation by targeting tumor necrosis factor receptor associated factor 4 in stroke-induced immunosuppression","volume":"27","author":"Li","year":"2020","journal-title":"Eur J Neurol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02372-z","article-title":"SNHG15 is a negative regulator of inflammation by mediating TRAF2 ubiquitination in stroke-induced immunosuppression","volume":"19","author":"Sun","year":"2022","journal-title":"J Neuroinflamm"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2025.110801","article-title":"Evaluating tocilizumab in ischemic stroke: Findings from the SPAN multicenter trial","volume":"285","author":"Chauhan","year":"2026","journal-title":"Neuropharmacology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"A128","DOI":"10.1161\/str.50.suppl_1.128","article-title":"Amelioration of ischemic stroke damage through inhibition of interleukin-6 signaling with tocilizumab requires sex specific dosing","volume":"50","author":"Hudobenko","year":"2019","journal-title":"Stroke"},{"key":"B32","doi-asserted-by":"publisher","first-page":"ATP270","DOI":"10.1161\/str.48.suppl_1.tp270","article-title":"Interleukin-6 receptor inhibition with tocilizumab ameliorates ischemic stroke damage in mice","volume":"48","author":"Hudobenko","year":"2017","journal-title":"Stroke"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2024-003574","article-title":"IRIS, a randomised, double-blind, placebo-controlled trial of interleukin-6 receptor inhibition undergoing endovascular treatment in acute anterior circulation ischaemic stroke: Study rationale and design","volume":"10","author":"Chu","year":"2025","journal-title":"Stroke Vasc Neurol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2026.106167","article-title":"Effect of IL-6 receptor inhibition on infarct volume after endovascular treatment for ischaemic stroke: A phase 2, randomised, placebo-controlled trial","volume":"125","author":"Chu","year":"2026","journal-title":"EBioMedicine"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-10-64","article-title":"White matter fractional anisotropy is related to processing speed in metabolic syndrome patients: A case-control study","volume":"10","author":"Segura","year":"2010","journal-title":"BMC Neurol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/s1474-4422(10)70104-6","article-title":"Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges","volume":"9","author":"Pantoni","year":"2010","journal-title":"Lancet Neurol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"23969873251349713","DOI":"10.1093\/esj\/23969873251349713","article-title":"Hemorrhagic transformation during inter-hospital transfer for thrombectomy: Incidence, associated factors, and relationship with outcome","volume":"11","author":"Seners","year":"2026","journal-title":"Eur Stroke J"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.25.6.1105","article-title":"Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke. Relation to acute confusional state, extent of brain damage, and clinical outcome","volume":"25","author":"Fassbender","year":"1994","journal-title":"Stroke"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1800891\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:21:44Z","timestamp":1786335704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1800891\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2026.1800891"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1800891","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"article-number":"1800891"}}